Bavarian Nordic A/S BVNKF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $20.45
- Day Range
- $21.20–21.20
- 52-Week Range
- $17.45–32.05
- Bid/Ask
- $23.27 / $28.11
- Market Cap
- $1.65 Bil
- Volume/Avg
- 1,319 / 392
Key Statistics
- Price/Earnings (Normalized)
- 7.28
- Price/Sales
- 1.70
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.06%
Company Profile
Bavarian Nordic A/S is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,381
- Website
- https://www.bavarian-nordic.com
Comparables
Valuation
Metric
|
BVNKF
|
GUBRA
|
NYKD
|
---|---|---|---|
Price/Earnings (Normalized) | 7.28 | 407.05 | — |
Price/Book Value | 1.12 | 10.15 | 2.73 |
Price/Sales | 1.70 | 22.13 | 39.42 |
Price/Cash Flow | 4.97 | — | — |
Price/Earnings
BVNKF
GUBRA
NYKD
Financial Strength
Metric
|
BVNKF
|
GUBRA
|
NYKD
|
---|---|---|---|
Quick Ratio | 1.02 | 6.40 | 8.43 |
Current Ratio | 1.64 | 6.45 | 8.43 |
Interest Coverage | 7.59 | −8.73 | — |
Quick Ratio
BVNKF
GUBRA
NYKD
Profitability
Metric
|
BVNKF
|
GUBRA
|
NYKD
|
---|---|---|---|
Return on Assets (Normalized) | 11.49% | −7.38% | −18.26% |
Return on Equity (Normalized) | 16.58% | −10.20% | −23.64% |
Return on Invested Capital (Normalized) | 16.63% | −8.49% | −26.98% |
Return on Assets
BVNKF
GUBRA
NYKD
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Knbnhmfl | Xtq | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Tbzhfdyr | Mkxhfkj | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bqlfmlw | Pcbqsr | $106.7 Bil | |
MRNA
| Moderna Inc | Dvcybhdwp | Mjypy | $50.9 Bil | |
ARGX
| argenx SE ADR | Wwnqhrrc | Mwbyp | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Wvmhdwr | Nbj | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Hjrjhrcbj | Vkqptc | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Wrdgpkw | Cbbgrc | $14.6 Bil | |
INCY
| Incyte Corp | Mjfdlkznh | Qhnqrcg | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Hrsfdylsvt | Wkpzqhm | $12.6 Bil |